MSL2
Basic information
Region (hg38): 3:136148917-136197241
Previous symbols: [ "RNF184", "MSL2L1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MSL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 20 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 1 | 0 |
Variants in MSL2
This is a list of pathogenic ClinVar variants found in the MSL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-136151169-A-G | not specified | Uncertain significance (Apr 12, 2024) | ||
3-136151239-C-G | Uncertain significance (Feb 08, 2023) | |||
3-136151244-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
3-136151256-C-A | Uncertain significance (Feb 08, 2023) | |||
3-136151311-T-A | Uncertain significance (Mar 12, 2024) | |||
3-136151356-T-G | not specified | Uncertain significance (May 27, 2022) | ||
3-136151430-T-C | Uncertain significance (Feb 14, 2024) | |||
3-136151466-CT-C | Uncertain significance (Apr 06, 2022) | |||
3-136151532-T-C | Uncertain significance (Feb 20, 2024) | |||
3-136151549-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
3-136151560-G-C | not specified | Uncertain significance (Oct 26, 2021) | ||
3-136151584-C-T | not specified | Likely benign (Apr 07, 2023) | ||
3-136151653-T-C | not specified | Uncertain significance (Dec 19, 2022) | ||
3-136151658-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
3-136151687-G-T | not specified | Uncertain significance (Dec 08, 2023) | ||
3-136151695-T-C | not specified | Uncertain significance (Sep 20, 2023) | ||
3-136151716-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
3-136151746-T-TG | Uncertain significance (Feb 04, 2022) | |||
3-136151772-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
3-136151778-GC-G | Autism | Uncertain significance (Apr 20, 2023) | ||
3-136151824-G-A | Uncertain significance (Aug 22, 2022) | |||
3-136151830-TCTCA-T | Syndromic neurodevelopmental disorder | Uncertain significance (Mar 26, 2022) | ||
3-136151874-G-C | Uncertain significance (Oct 24, 2022) | |||
3-136151889-G-C | not specified | Uncertain significance (May 18, 2022) | ||
3-136151910-T-A | not specified | Uncertain significance (Nov 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MSL2 | protein_coding | protein_coding | ENST00000309993 | 2 | 48320 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.624 | 0.376 | 125737 | 0 | 4 | 125741 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.00 | 210 | 309 | 0.679 | 0.0000166 | 3789 |
Missense in Polyphen | 38 | 96.425 | 0.39409 | 1227 | ||
Synonymous | -2.27 | 146 | 115 | 1.27 | 0.00000619 | 1164 |
Loss of Function | 3.03 | 3 | 16.1 | 0.186 | 9.73e-7 | 226 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at lysine 16 which is implicated in the formation of higher-order chromatin structure. Acts as an E3 ubiquitin ligase that promotes monoubiquitination of histone H2B at 'Lys-35' (H2BK34Ub), but not that of H2A. This activity is greatly enhanced by heterodimerization with MSL1. H2B ubiquitination in turn stimulates histine H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1. {ECO:0000269|PubMed:21726816}.;
- Pathway
- Chromatin modifying enzymes;TCR;HATs acetylate histones;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.00717
- rvis_EVS
- -0.53
- rvis_percentile_EVS
- 20.7
Haploinsufficiency Scores
- pHI
- 0.972
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.903
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Msl2
- Phenotype
Gene ontology
- Biological process
- protein ubiquitination;histone H4-K16 acetylation
- Cellular component
- nucleoplasm;MSL complex
- Molecular function
- metal ion binding;ubiquitin protein ligase activity